Comment on: Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome

2018

Additional data suggest that rivaroxaban does not seem to be efficient in all APS patients.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

6

References

3

Citations